BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 175 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $563,000 | -22.1% | 7,662 | 0.0% | 0.76% | -11.3% |
| Q2 2019 | $723,000 | +4.3% | 7,662 | -11.5% | 0.86% | -11.0% |
| Q1 2019 | $693,000 | -30.6% | 8,662 | -53.2% | 0.96% | -28.7% |
| Q4 2018 | $999,000 | -55.9% | 18,528 | -36.2% | 1.35% | -36.4% |
| Q3 2018 | $2,267,000 | +23.0% | 29,036 | 0.0% | 2.12% | +25.7% |
| Q2 2018 | $1,843,000 | -29.8% | 29,036 | +1.4% | 1.69% | -38.6% |
| Q1 2018 | $2,627,000 | +21.6% | 28,646 | 0.0% | 2.75% | +24.7% |
| Q4 2017 | $2,160,000 | +25.4% | 28,646 | +15.8% | 2.21% | +4.6% |
| Q3 2017 | $1,723,000 | +46.1% | 24,735 | +6.3% | 2.11% | +18.2% |
| Q2 2017 | $1,179,000 | – | 23,273 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |